Position in ARVN
as of Mar 31, 2026
· filed May 19, 2026
Position Value
$1,060
New position
Shares Held
100
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026FLAX POND CAPITAL, LLC holds $17,260,262 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QURE |
uniQure N.V.
|
156,726 | $7,218,799 | |
| 2 | NRIX |
Nurix Therapeutics, Inc.
|
79,700 | $1,933,522 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
36,000 | $1,932,120 | |
| 4 | RARE |
Ultragenyx Pharmaceutical Inc.
|
56,838 | $1,897,820 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
41,302 | $1,539,325 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
7,933 | $1,485,692 | |
| 7 | BCYC |
Bicycle Therapeutics PLC
|
180,086 | $763,564 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
6,000 | $489,420 |
All Filings in ARVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,060 | 100 | Shares | Sole | 2026-05-19 | |
| No filing history on record for this holder in this stock. | ||||||